Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-0500
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria ; volume:15 ; number:1 ; day:2 ; month:10 ; year:2022 ; pages:1-4 ; date:12.2022
BMC Research Notes / Biomed Central; 15, Heft 1 (2.10.2022), 1-4, 12.2022
- Creator
-
Tarning, Joel
Seidlein, Lorenz von
Dondorp, Arjen M.
White, Nicholas J.
Maude, Richard J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13104-022-06212-y
- URN
-
urn:nbn:de:101:1-2022122021081034858039
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tarning, Joel
- Seidlein, Lorenz von
- Dondorp, Arjen M.
- White, Nicholas J.
- Maude, Richard J.
- SpringerLink (Online service)
Other Objects (12)
The diminishing returns of atovaquone-proguanil for elimination of Plasmodium falciparum malaria: modelling mass drug administration and treatment
The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum
Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900
Spread of anti-malarial drug resistance: Mathematical model with implications for ACT drug policies
The fluid management of adults with severe malaria
How antimalarial drug resistance affects post-treatment prophylaxis
Anaemia and malaria
Anti‐malarial drug effects on parasite dynamics in vivax malaria
Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
Malaria parasite clearance
The role of anti-malarial drugs in eliminating malaria
Determinants of relapse periodicity in Plasmodium vivax malaria
The diminishing returns of atovaquone-proguanil for elimination of Plasmodium falciparum malaria: modelling mass drug administration and treatment
The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum
Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900
Spread of anti-malarial drug resistance: Mathematical model with implications for ACT drug policies
The fluid management of adults with severe malaria
How antimalarial drug resistance affects post-treatment prophylaxis
Anaemia and malaria
Anti‐malarial drug effects on parasite dynamics in vivax malaria
Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
Malaria parasite clearance
The role of anti-malarial drugs in eliminating malaria
Determinants of relapse periodicity in Plasmodium vivax malaria
The diminishing returns of atovaquone-proguanil for elimination of Plasmodium falciparum malaria: modelling mass drug administration and treatment
The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum
Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900
Spread of anti-malarial drug resistance: Mathematical model with implications for ACT drug policies
The fluid management of adults with severe malaria
How antimalarial drug resistance affects post-treatment prophylaxis
Anaemia and malaria
Anti‐malarial drug effects on parasite dynamics in vivax malaria
Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
Malaria parasite clearance
The role of anti-malarial drugs in eliminating malaria